News

As part of the deal, Caprion will identify blood-based protein markers for the GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions) trial. GLOBAL is a pan-omic study that

The deal includes a licensing fee, milestone payments and royalties based on product sales. The company said that the pharmaceutical partner is dedicated to dermatology with an extensive

The pharmaceutical partner is dedicated to dermatology with an extensive product portfolio available in 80 countries. The long-term license deal, which provides for upfront and milestone payments and

Combination of Empiriko’s chemosynthetic livers and Interchim’s innovative instrumentation and expertise in the field of liquid chromatography allows pharmaceutical scientists to predict metabolism patterns, pathways and profiles, while

A second NOA has been received for US Patent Application Serial No. 11/782,838 entitled ‘Controlled-release pharmaceutical tablets’ which is related to the drug delivery technology used in Forfivo

The call for proposals comes after newly released recommendations from the Society for Healthcare Epidemiology of America (SHEA) shed light on the issue of contaminated healthcare personnel apparel

The allowed claims for US Patent Application No. 12/528,690 entitled ‘Composition and Methods for Modulating Cell Proliferation and Cell Death’, cover a core element of Rosetta Genomics’ microRNA

The patent covers the company’s carbohydrate-based galectin inhibitor compound GR-MD-02 for use in patients with fatty liver disease with or without fibrosis or cirrhosis, providing patent protection through

The patent covers all of the company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a concentrated formulation to be given in low volume